137 related articles for article (PubMed ID: 22272341)
1. Stepwise optimization of the procedure for assessment of circulating progenitor cells in patients with myocardial infarction.
Cui YX; Johnson T; Baumbach A; Reeves BC; Rogers CA; Angelini GD; Marsden D; Madeddu P
PLoS One; 2012; 7(1):e30389. PubMed ID: 22272341
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
[TBL] [Abstract][Full Text] [Related]
3. Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.
Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT; Topel ML; Grant AJ; Sabbak N; Heinl RE; Gafeer MM; Obideen M; Kaseer B; Abdelhadi N; Ko YA; Liu C; Hesaroieh I; Mahar EA; Vaccarino V; Waller EK; Quyyumi AA
Circ Res; 2018 May; 122(11):1565-1575. PubMed ID: 29514830
[TBL] [Abstract][Full Text] [Related]
4. Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction.
Brehm M; Picard F; Ebner P; Turan G; Bölke E; Köstering M; Schüller P; Fleissner T; Ilousis D; Augusta K; Peiper M; Schannwell Ch; Strauer BE
Eur J Med Res; 2009 Sep; 14(9):393-405. PubMed ID: 19748858
[TBL] [Abstract][Full Text] [Related]
5. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
[TBL] [Abstract][Full Text] [Related]
6. Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience.
Limsuwan A; Pienvichit P; Limpijankit T; Khowsathit P; Hongeng S; Pornkul R; Siripornpitak S; Boonbaichaiyapruk S
Clin Cardiol; 2010 Aug; 33(8):E7-12. PubMed ID: 20632394
[TBL] [Abstract][Full Text] [Related]
7. Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction.
Grundmann F; Scheid C; Braun D; Zobel C; Reuter H; Schwinger RH; Müller-Ehmsen J
Clin Res Cardiol; 2007 Sep; 96(9):621-7. PubMed ID: 17676354
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus impairs CD133+ progenitor cell function after myocardial infarction.
Vöö S; Dunaeva M; Eggermann J; Stadler N; Waltenberger J
J Intern Med; 2009 Feb; 265(2):238-49. PubMed ID: 19019194
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.
Aonuma T; Takehara N; Maruyama K; Kabara M; Matsuki M; Yamauchi A; Kawabe J; Hasebe N
Stem Cells Transl Med; 2016 Aug; 5(8):1067-78. PubMed ID: 27334489
[TBL] [Abstract][Full Text] [Related]
10. Circulating Progenitor Cells and Racial Differences.
Samman Tahhan A; Hammadah M; Kelli HM; Kim JH; Sandesara PB; Alkhoder A; Kaseer B; Gafeer MM; Topel M; Hayek SS; O'Neal WT; Obideen M; Ko YA; Liu C; Hesaroieh I; Mahar E; Vaccarino V; Waller EK; Quyyumi AA
Circ Res; 2018 Aug; 123(4):467-476. PubMed ID: 29930146
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations.
Shaffer RG; Greene S; Arshi A; Supple G; Bantly A; Moore JS; Mohler ER
Cytometry B Clin Cytom; 2006 Mar; 70(2):56-62. PubMed ID: 16456866
[TBL] [Abstract][Full Text] [Related]
12. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year.
Tang XL; Li Q; Rokosh G; Sanganalmath SK; Chen N; Ou Q; Stowers H; Hunt G; Bolli R
Circ Res; 2016 Apr; 118(7):1091-105. PubMed ID: 26838790
[TBL] [Abstract][Full Text] [Related]
14. Circulating CD34+/133+ progenitor cells in patients with stable angina pectoris undergoing percutaneous coronary intervention.
Arao K; Yasu T; Ohmura N; Tsukamoto Y; Murata M; Kubo N; Umemoto T; Ikeda N; Ako J; Ishikawa SE; Kawakami M; Momomura S
Circ J; 2010 Sep; 74(9):1929-35. PubMed ID: 20625217
[TBL] [Abstract][Full Text] [Related]
15. Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction.
Vöö S; Eggermann J; Dunaeva M; Ramakers-van Oosterhoud C; Waltenberger J
Eur Heart J; 2008 Jan; 29(2):241-50. PubMed ID: 18156140
[TBL] [Abstract][Full Text] [Related]
16. Changes in circulating progenitor cells are associated with outcome in heart failure patients: a longitudinal study.
Alba AC; Lalonde SD; Rao V; Walter SD; Guyatt GH; Ross HJ
Can J Cardiol; 2013 Dec; 29(12):1657-64. PubMed ID: 24054922
[TBL] [Abstract][Full Text] [Related]
17. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics.
Lucchinetti E; Zeisberger SM; Baruscotti I; Wacker J; Feng J; Zaugg K; Dubey R; Zisch AH; Zaugg M
Anesth Analg; 2009 Oct; 109(4):1117-26. PubMed ID: 19762739
[TBL] [Abstract][Full Text] [Related]
18. Flow-cytometric identification, enumeration, purification, and expansion of CD133+ and VEGF-R2+ endothelial progenitor cells from peripheral blood.
Rustemeyer P; Wittkowski W; Greve B; Stehling M
J Immunoassay Immunochem; 2007; 28(1):13-23. PubMed ID: 17236393
[TBL] [Abstract][Full Text] [Related]
19. Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting.
Oshima Y; Suzuki A; Kawashimo K; Ishikawa M; Ohkohchi N; Taniguchi H
Gastroenterology; 2007 Feb; 132(2):720-32. PubMed ID: 17258722
[TBL] [Abstract][Full Text] [Related]
20. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
